Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | APAF1 | O14727 | 1/20 | 0.50 |
| ▸ | RGS12 | O14924 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Protocatechuamide SCHEMBL1128716 | 0.84 | LCK (0.65) | CA12CA1CA2CA7CA9 | |
| Terephthalamide SCHEMBL28398318 | 0.82 | MEN1 (0.67) | CA1CA2MEN1APAF1RGS12 | |
| Terephthalamide SCHEMBL28497793 | 0.82 | MEN1 (0.67) | CA1CA2MEN1APAF1RGS12 | |
| Terephthalamide SCHEMBL17074059 | 0.82 | MEN1 (0.67) | CA1CA2MEN1APAF1RGS12 | |
| Dodecane SCHEMBL9222476 | 0.82 | MEN1 (0.67) | CA1CA2MEN1APAF1RGS12 | |
| Tetradecane SCHEMBL9312928 | 0.82 | MEN1 (0.67) | CA1CA2MEN1APAF1RGS12 | |
| Protocatechuamide SCHEMBL28613093 | 0.82 | LCK (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10489570 | 0.81 | HSD17B3 (0.67) | MEN1KMT2AAPPTRPV1MAPT | |
| SCHEMBL5677489 | 0.81 | HSD17B3 (0.67) | MEN1KMT2AAPPTRPV1MAPT | |
| SCHEMBL10352970 | 0.81 | HSD17B3 (0.67) | MEN1KMT2AAPPTRPV1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101765367-A | Substances for the protection of cells and/or tissues | RALF LOESEL | 2010-06-30 | — | — | CN | disclosed |
| US-20100129436-A1 | SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES | LOSEL RALF | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129436-A1 | SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES | CTSA, BCL2, BAX | CA12 1364/4885CA1 1014/4885CA2 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.